Usana Health Sciences Inc balance sheet

At the end of fiscal 2025, Usana Health Sciences Inc had total assets of $743m, total liabilities of $157m and shareholders' equity of $533m. It held $158m in cash against $14.0m of debt: net cash of $144m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Usana Health Sciences Inc: balance sheet, annual
Fiscal year	2009Jan 2010	2010Jan 2011	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Jan 2015	2015Jan 2016	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Jan 2021	2021Jan 2022	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Jan 2026	LTMJul 2026
Cash and equivalents	14	50	50	71	137	111	143	176	247	214	235	312	240	288	330	182	158	169
Receivables	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	4	3
Inventory	—	34	37	36	47	45	66	65	63	82	69	90	98	67	61	70	103	86
Total current assets	—	82	106	133	229	191	244	278	340	392	329	425	365	384	418	279	288	281
Goodwill	—	17	18	18	18	18	17	17	17	17	17	17	18	17	17	144	138	109
Total assets	—	217	244	267	368	351	423	471	519	554	517	641	578	597	633	748	743	703
Accounts payable	—	6	8	7	10	8	10	9	12	10	13	18	14	11	10	12	17	15
Deferred revenue (current)	—	—	10	16	16	16	18	21	3	3	14	16	20	21	14	12	11	—
Total current liabilities	—	59	60	71	96	109	131	138	141	149	136	168	161	144	119	140	129	106
Total debt	0	0	0	0	0	0	0	—	0	0	0	0	0	0	1	23	14	0
Total liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	136	162	157	132
Shareholders' equity	74	147	174	186	261	230	281	325	363	391	352	442	395	434	497	532	533	526
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	54	53	45
Net debt (negative = net cash)	−14	−50	−50	−71	−137	−111	−143	−176	−247	−214	−235	−312	−240	−288	−330	−159	−144	−169
Shares outstanding	31m	32m	30m	28m	28m	25m	25m	24m	24m	24m	22m	21m	19m	19m	19m	19m	18m	18m

US$ millions unless shown otherwise. Fiscal quarters.

Usana Health Sciences Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Jan 2026	2026 Q1Apr 2026	2026 Q2Jul 2026
Receivables	—	—	—	—	—	4	10	3
Inventory	64	70	74	83	91	103	96	86
Total current assets	451	279	281	262	264	288	294	281
Goodwill	17	144	144	144	144	138	138	109
Total assets	671	748	747	735	727	743	739	703
Accounts payable	7	12	14	18	16	17	16	15
Deferred revenue (current)	—	12	—	—	—	11	—	—
Total current liabilities	115	140	137	122	119	129	117	106
Total liabilities	—	162	163	149	145	157	144	132
Shareholders' equity	533	532	530	531	528	533	544	526
Non-controlling interests and other (assets − liabilities − equity)	—	54	54	54	53	53	51	45
Shares outstanding	19m	19m	19m	18m	18m	18m	18m	18m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ODD vs USNA NUS vs USNA IPAR vs USNA NATR vs USNA

More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies

Figures from Usana Health Sciences Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Usana Health Sciences Inc.